« A real alternative to plastic surgery, Cosmosoft devices guarantee effective and lasting reshaping of the body. Clinically proven, BioStimology promises rapid, painless results and is part of the brand’s growing notoriety. »
Cosmosoft is a French designer, manufacturer and distributor of professional health and beauty equipments since 1998. The company relies on a unique, patented technology: BioStimology.
With more than 15 years of experience, Cosmosoft is positioned today as a world leader in low frequency alternating bioenergetic fields.
Keen to provide a complementary tool in the management of fat overload, Cosmosoft offers « soft » care with scientifically proven and sustainable results. Painless and without side effects, BioStimology is the ONLY technology in the world able to reduce visceral and subcutaneous fat.
+ 15 years of research
Unique and patented technology
The ONLY technology
able to reduce
visceral
and subcutaneous fats
A non-intrusive and
no side effect procedure
More than 2500 spas and institutes worldwide
Cosmosoft was founded and launched its first slimming device: BodySculptor BS11. With thigh and abdomen straps, it was one of the first 100% hands-free devices on the slimming market.
Launch of the slimming device BodySculptor BS22. A more comprehensive device with 2 additional straps for arms or calves.
Launch of BodySculptor exCell: the first slimming device to combine low frequency alternating bioenergetic fields and micropressure for 100% hands-free treatment.
A predictive study on DNA chips by Dr Benech helped to decipher the biological action of Cosmosoft devices.
Launch of ReduStim: the first Class IIa medical (CE 0476) device for reducing abdominal obesity.
Study of the impact of ReduStim on improving female fertility showing a doubling of the pregnancy rate after IVF.
Study of the impact of ReduStim SPort on visceral fat reduction.
Launch of the dynamic medical device ReduStim SPort.
Prospective pilot study on Diabetes by Dr. Imholz: reduction in visceral fat has a positive influence on Diabetes regulation.
An observative pilot study by Dr Plasqui showed an increase around 30% of energy expenditure in combination with a cardio session.
Proud of its technological progress and continuing success in a constantly evolving market, the French company has fifty collaborators split between the company headquarters and training centre at Levallois-Perret, the production unit in Tunisia and our exclusive distributor in Dubai that covers Asia and Middle East countries.
Siret number 441 011 988 000 33
